Linkedin Twitter Limerick Ladies National Football League opener to be streamed live Print Previous articleLimerick Man Launches new HR Tech CompanyNext articleThree months of diversion in Adare David Raleigh RELATED ARTICLESMORE FROM AUTHOR LimerickNewsClinicians must give go-ahead for patients to be moved from UHLBy David Raleigh – January 26, 2020 786 Billy Lee names strong Limerick side to take on Wicklow in crucial Division 3 clash Senator Kieran O’Donnell at St John’s Hospital.PATIENTS will only be transferred from the consistently overcrowded University Hospital Limerick (UHL) to vacant beds at the nearby St John’s Hospital only when it is deemed safe to do so.Fine Gael Senator Kieran O’Donnell said he was informed there were ten vacant beds this morning at St John’s on Monday morning when there were 50 patients waiting for beds at UHL.Sign up for the weekly Limerick Post newsletter Sign Up Both are managed by the UL Hospitals Group, which also includes the University Maternity Hospital Limerick; Mid Western Regional Hospital, Ennis; Nenagh General Hospital; and Croom Orthopaedic Hospital.Of the 50 patients awaiting beds at UHL, 23 were on trolleys in the emergency department and 27 on trolleys on wards.Senator O’Donnell said he contacted the UL Hospitals Group asking management to confirm if transfers would take place to St John’s to take up the ten vacant beds.He said management later informed him that the vacant beds would be filled if the clinicians deemed it safe to transfer the patients,otherwise they would be filled through St John’s Medical Assessment Unit (MAU).However, a UL Hospitals Group spokesman told the Limerick Post on Monday evening that there were six beds available at St John’s Hospital at 8am that morning.“As occurs every day, patients from UHL will be transferred to St John’s following a clinical decision and in line with national policy on which patients are appropriate to be cared for in Model 2 hospitals.”“At 11am this morning, there were three patients identified for transfer. St John’s Hospital, as is the norm, will have admissions from their own medical assessment unit which is fully operational today.”“Where patients are identified as suitable for an inter-hospital transfer, that transfer is only effected once all the necessary arrangements have been agreed between the clinical teams and bed management at both the transferring and receiving hospital.”“On a typical day at UL Hospitals Group, approximately 15 patients are transferred from UHL to the Model 2 hospitals at St John’s, Ennis and Nenagh,” the spokesman added.On Sunday, Tanaiste Simon Coveney promised Fine Gael would “fix the trolley crisis by making further investment in beds and staff”.Speaking outside Thomond Park, Mr Coveney told reporters: “Because of a strong growing economy, we now can make realistic financial commitments to add extra beds, extra staff into the system, and fix, once and for all, the accident and emergency pressures we are seeing in Limerick.”A 60-bed modular unit is currently being built on the grounds of UHL, and management has sought a further 96-bed unit. WATCH: “Everyone is fighting so hard to get on” – Pat Ryan on competitive camogie squads WhatsApp Donal Ryan names Limerick Ladies Football team for League opener Limerick’s National Camogie League double header to be streamed live Email Facebook TAGSKeeping Limerick PostedlimerickLimerick Post Predictions on the future of learning discussed at Limerick Lifelong Learning Festival Advertisement
Questlove has launched an exclusive popcorn collaboration with kitchen retailer Williams Sonoma. The Grammy Award-winning musician and co-founder of the legendary The Roots was inspired by his love of popcorn and design to develop a line of products that create the ultimate experience for his fellow popcorn lovers.Questlove’s new product line, The Questlove for Williams Sonoma Collection, features everything you need to season and serve popcorn, including cold-pressed avocado spray oil, lemon pepper seasoning, Saturday morning cereal seasoning, truffle parm rosemary seasoning, a glow bowl, and a special Questlove “SNEAKIES Set”. The “SNEAKIES set” includes a pocket-sized pack of all three seasoning flavors, designed for seasoning on the go and “sneaking” into the movie theatre.As Questlove explains in a statement,Movies and popcorn are one of the classic pairs in Western Civilization, like Starsky and Hutch or Ashford and Simpson. Being an avid movie-goer and huge popcorn fan, I wanted to create my own popcorn collection and give it a personal Questovian spin, in two directions. The first is my custom seasonings, which let you put extra punctuation on the sentence of your popcorn, either directly from the shaker or SNEAKIES, with the help of a good spray of avocado oil for full seasoning coverage. The second is the Glow Bowl I designed that will make your popcorn happy when it’s laying in there and you happy when you’re scooping it up with your hands on date night or at a holiday gathering.The Questlove for Williams Sonoma Collection will be sold exclusively at Williams Sonoma. For more information and to purchase items from the Questlove for Williams Sonoma Collection, head here.The Roots are gearing up for their upcoming five-show New Year’s run, or as the legendary crew likes to call it, their “holiday tour.” The band will focus on the Eastern Seaboard over the course of their five-show stint.The Roots will start the run at Boston’s House Of Blues on Wednesday, December 26th, before heading south to Montclair, NJ’s Wellmont Theatre the following evening, Thursday, December 27th. The Roots then continue south with a show at Silver Spring, MD’s Fillmore on Friday, December 28th, and then hit Miami Beach, FL’s Fillmore, on Sunday, December 30th, following a night off on the 29th. The five-show run will conclude with an NYE show at Atlanta, GA’s Coca-Cola Roxy.
Aug 14, 2009 (CIDRAP News) – Federal officials today during a pandemic H1N1 planning update dialed back the number of novel flu vaccine doses they expect in October from 120 million to 45 million, listing several reasons for the smaller projection.During a late July meeting of a federal immunization advisory panel, which targeted 159 million people to receive the first doses, authorities projected that 120 million doses would be available in October, with another 80 million per month in the following months.However, during a National Biodefense Safety Board (NBSB) teleconference today, Dr. Robin Robinson, director of the Biological Advanced Research and Development Authority (BARDA) at the US Department of Health and Human Services (HHS), said the latest expectation is 45 million doses by mid October, with manufacturers delivering 20 million doses per week after that.He said the revised estimate is based on several factors expected to slow vaccine delivery from manufacturers. Health officials have already acknowledged that yields of the novel H1N1 antigen are less than for the seasonal flu vaccine. Robinson also said vaccine makers have a limited number of fill-and-finish sites, which are just completing seasonal flu vaccine production, but that federal officials are looking for ways to maximize the current capacity.CSL Biotherapies, an Australian company that is one of the five manufacturers making pandemic H1N1 vaccine for the US market, has a contractual obligation to produce vaccine first for its home country, Robinson said. Because Australia is in the midst of the Southern Hemisphere’s flu season, the United States will work with CSL to ensure that it can deliver vaccine doses to both countries.Another factor that has added to the delay in ramping up production of the novel flu vaccine is that one of the companies making seasonal flu vaccine is having problems finishing up production so that it can clear the decks to make novel flu vaccine, Robinson said. The delay has impacted vaccine timelines by 4 to 6 weeks, he said.A new seed strain developed to replace the slower-growing strain in lab studies looks like it will produce better novel H1N1 antigen yields that are on par with those for the seasonal vaccine, Robinson said, adding that federal officials will be working with manufacturers over the next 2 weeks to see if the improved yields are also seen in commercial production.In an update on the nation’s antiviral stockpiles, Robin said that 84 million treatment courses are currently in federal and state stockpiles and that 3 million more doses are expected soon. He projected that a total of 100 million antiviral treatment courses will be available this fall, but he added that only a small amount will be available commercially.Federal officials are currently discussing if the experimental antiviral drug peramivir should be allowed under an emergency use authorization (EUA) for treating critically ill seasonal or novel flu patients. He said a final decision would be made soon. Peramivir, a neuraminidase inhibitor developed by BioCryst Pharmaceuticals, can be given by intravenous (IV) or intramuscular (IM) routes. Phase 2 study results of the drug were disappointing. However, the company announced in mid July that initial phase 3 study of an IV version of the drug conducted in Asia showed that the drug was safe and well tolerated.During the comment part of the meeting, some of the NBSB board members and members of the public expressed concerns about the current lack of an IV or IM antiviral treatment, urging officials to strongly consider approving an EUA for peramivir.See also:Jul 17 BioCryst press releaseJul 29 CIDRAP News story “ACIP targets up to 159 million Americans for H1N1 vaccination”